These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31857543)

  • 1. Loss of
    Malgulwar PB; Kakkar A; Sharma MC; Ghosh R; Pathak P; Sarkar C; Suri V; Singh M; Kale SS; Faruq M
    Neurol India; 2019; 67(6):1492-1497. PubMed ID: 31857543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
    van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
    Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of INI1 Expression-Understanding the Molecular Basis of Chordoid Meningiomas.
    Tiwari M; Saxena AK; Sharma LK
    Neurol India; 2019; 67(6):1498-1499. PubMed ID: 31857544
    [No Abstract]   [Full Text] [Related]  

  • 4. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
    Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
    Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INI1 mutations in meningiomas at a potential hotspot in exon 9.
    Schmitz U; Mueller W; Weber M; Sévenet N; Delattre O; von Deimling A
    Br J Cancer; 2001 Jan; 84(2):199-201. PubMed ID: 11161377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
    Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
    J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
    Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
    Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
    Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
    Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
    Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
    Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCB1 mutations are not a common cause of multiple meningiomas.
    Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
    J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes.
    Baal JD; Chen WC; Solomon DA; Pai JS; Lucas CH; Hara JH; Oberheim Bush NA; McDermott MW; Raleigh DR; Villanueva-Meyer JE
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):433-439. PubMed ID: 30819773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chordoid meningioma: a report of ten cases.
    Tena-Suck ML; Collado-Ortìz MA; Salinas-Lara C; García-López R; Gelista N; Rembao-Bojorquez D
    J Neurooncol; 2010 Aug; 99(1):41-8. PubMed ID: 20094774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrotic rhabdoid meningiomas with aggressive clinical behavior.
    Matyja E; Grajkowska W; Nauman P; Bonicki W; Bojarski P; Marchel A
    Clin Neuropathol; 2010; 29(5):307-16. PubMed ID: 20860894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline and somatic mutations in meningiomas.
    Smith MJ
    Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT.
    Jungwirth G; Warta R; Beynon C; Sahm F; von Deimling A; Unterberg A; Herold-Mende C; Jungk C
    Acta Neuropathol Commun; 2019 Aug; 7(1):140. PubMed ID: 31470906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SWI/SNF chromatin remodeling complex alterations in meningioma.
    Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3431-3440. PubMed ID: 33715086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular heterogeneity of meningioma with INI1 mutation.
    Rieske P; Zakrzewska M; Piaskowski S; Jaskólski D; Sikorska B; Papierz W; Zakrzewski K; Liberski PP
    Mol Pathol; 2003 Oct; 56(5):299-301. PubMed ID: 14514925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.
    Boetto J; Bielle F; Sanson M; Peyre M; Kalamarides M
    Neuro Oncol; 2017 Mar; 19(3):345-351. PubMed ID: 28082415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKT1
    John P; Waldt N; Liebich J; Kesseler C; Schnabel S; Angenstein F; Sandalcioglu IE; Scherlach C; Sahm F; Kirches E; Mawrin C
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12780. PubMed ID: 34837233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.